$SLAB

SILICON LABORATORIES INC

CIK:0001038074|SEC Filings

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 04, 2026	Jul. 05, 2025	Jul. 04, 2026	Jul. 05, 2025
Income Statement [Abstract]
Revenues	$ 228,189	$ 192,845	$ 441,689	$ 370,559
Cost of revenues	87,515	84,736	174,017	164,673
Gross profit	140,674	108,109	267,672	205,886
Operating expenses:
Research and development	95,016	87,821	183,610	176,040
Selling, general and administrative	56,324	43,155	111,810	84,793
Operating expenses	151,340	130,976	295,420	260,833
Operating loss	(10,666)	(22,867)	(27,748)	(54,947)
Other income (expense):
Interest income and other, net	2,489	3,833	6,115	7,626
Interest expense	(251)	(251)	(483)	(535)
Loss before income taxes	(8,428)	(19,285)	(22,116)	(47,856)
Provision for income taxes	2,164	2,532	4,373	4,431
Net loss	$ (10,592)	$ (21,817)	$ (26,489)	$ (52,287)
Loss per share:
Basic (in dollars per share)	$ (0.32)	$ (0.67)	$ (0.80)	$ (1.61)
Diluted (in dollars per share)	$ (0.32)	$ (0.67)	$ (0.80)	$ (1.61)
Weighted-average common shares outstanding:
Basic (in shares)	33,206	32,682	33,084	32,570
Diluted (in shares)	33,206	32,682	33,084	32,570

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 04, 2026	Jul. 05, 2025
Operating Activities
Net loss	$ (26,489)	$ (52,287)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property and equipment	12,171	12,701
Amortization of other intangible assets	4,589	8,780
Stock-based compensation expense	46,704	39,605
Deferred income taxes	1,663	1,504
Changes in operating assets and liabilities:
Accounts receivable	(15,289)	(2,017)
Inventories	(27,734)	24,631
Prepaid expenses and other assets	(803)	5,112
Accounts payable	2,051	12,812
Other current liabilities and income taxes	(7,925)	8,377
Deferred revenue and returns liability	(183)	783
Other non-current liabilities	1,667	(6,965)
Net cash provided by (used in) operating activities	(9,578)	53,036
Investing Activities
Purchases of marketable securities	0	(32,507)
Sales of marketable securities	0	14,986
Maturities of marketable securities	44,119	17,019
Purchases of property and equipment	(22,153)	(13,549)
Proceeds from capital-related government incentives	5,272	0
Net cash provided by (used in) investing activities	27,238	(14,051)
Financing Activities
Payment of taxes withheld for vested stock awards	(27,451)	(13,752)
Proceeds from the issuance of common stock	7,760	7,619
Net cash used in financing activities	(19,691)	(6,133)
Increase (decrease) in cash and cash equivalents	(2,031)	32,852
Cash and cash equivalents at beginning of period	364,222	281,607
Cash and cash equivalents at end of period	$ 362,191	$ 314,459

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 04, 2026	Jan. 03, 2026
Current assets:
Cash and cash equivalents	$ 362,191	$ 364,222
Short-term investments	35,051	79,400
Accounts receivable, net	79,801	64,513
Inventories	123,340	95,566
Prepaid expenses and other current assets	70,840	70,316
Total current assets	671,223	674,017
Property and equipment, net	130,902	128,643
Goodwill	376,389	376,389
Other intangible assets, net	18,541	23,130
Other assets, net	56,001	67,138
Total assets	1,253,056	1,269,317
Current liabilities:
Accounts payable	52,407	50,717
Deferred revenue and returns liability	5,176	5,359
Other current liabilities	66,563	87,711
Total current liabilities	124,146	143,787
Other non-current liabilities	34,108	31,112
Total liabilities	158,254	174,899
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued	0	0
Common stock – $0.0001 par value; 250,000 shares authorized; 33,366 and 32,955 shares issued and outstanding at July 4, 2026 and January 3, 2026, respectively	3	3
Additional paid-in capital	184,456	157,402
Retained earnings	910,325	936,814
Accumulated other comprehensive income	18	199
Total stockholders’ equity	1,094,802	1,094,418
Total liabilities and stockholders’ equity	$ 1,253,056	$ 1,269,317